Gain Therapeutics, Inc. (GANX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Gain Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.27x | -2.42x | -1.91x | -2.11x | -3.97x | -37.18x |
| P/B Ratio | 5.72x | 6.73x | 3.38x | 1.97x | 1.59x | 21.45x |
| P/S Ratio | 0.00x | 0.00x | 771.06x | 280.42x | 412.15x | 4605.67x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | -6114.6% | -5249.3% | 100.0% |
| Operating Margin | 0.0% | 0.0% | -40328.3% | -13402.5% | -10323.6% | -12047.5% |
| Net Margin | 0.0% | 0.0% | -40354.3% | -13262.0% | -10371.7% | -12387.7% |
| EBITDA Margin | 0.0% | 0.0% | -40176.8% | -13390.1% | -10320.5% | -12014.3% |
| Liquidity | ||||||
| Current Ratio | 6.63x | 2.97x | 3.59x | 5.11x | 14.78x | 4.25x |
| Quick Ratio | 6.63x | 2.97x | 3.59x | 5.11x | 14.78x | 4.25x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.09x | 0.08x | 0.07x | 0.05x | 0.20x |
YoY = year-over-year change. Source: FMP..